Comment on Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. 2021, , 1176.

Cancers (Basel)

Department of Oncology, Institut Gustave Roussy, 94805 Villejuif, France.

Published: July 2021

We read, with great interest, the recently published article by Hopkins et al. [...].

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8307040	PMC
http://dx.doi.org/10.3390/cancers13143624	DOI Listing

Publication Analysis

comment hopkins

hopkins lung

lung immune

immune prognostic

prognostic patients

patients non-small

non-small cell

cell lung

lung cancer

cancer initiating

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!